Clinical trial reportCancerPublished
Intratumoral vidutolimod as monotherapy or in combination with pembrolizumab in patients with programmed cell death 1 blockade-resistant melanoma: Final analysis from a phase 1b study
Regional connection
Verified Author affiliations on the Europe PMC record name Fox Chase Cancer Center, Thomas Jefferson University, with Temple Health linked by the institution reference. Affiliation source
- Institutions
- Fox Chase Cancer Center, Temple Health, Thomas Jefferson University
- County
- Philadelphia County
Publication record
- Type
- Clinical trial report
- Venue
- Cancer
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Melanoma; Skin Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Drug Resistance, Neoplasm; Adult; Aged; Aged, 80 and over; Middle Aged; Female; Male; Antibodies, Monoclonal, Humanized
- PubMed ID
- 40753466
- PubMed Central ID
- PMC12318270
- Open access
- Yes, open
- Added to directory
- Source checked